$CCEP

UBS Downgrades Coca-Cola Europacific Partners to Neutral From Buy, Adjusts PT to $107 From $109

UBS downgraded Coca-Cola Europacific Partners to Neutral from Buy and cut its price target to $107 from $109, according to the note. The change affects investor expectations for the company’s valuation and outlook.

Original reporting
Published Aug 13, 2026, 1:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CCEP
Neutral
medium confidence
Mentioned
$CCEP
Relevance
6/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CCEPNeutralLow
01

Why it matters

A rating downgrade typically affects short-term positioning and expectations, but the text lacks any new company-specific operational or financial datapoint.

02

Market read

This is a sentiment and expectations update for CCEP driven by an analyst downgrade, not by new fundamentals.

03

What to watch

Traders may discount PT changes if consensus estimates and near-term catalysts (earnings, volume trends) are unchanged; relative positioning versus other beverage distributors matters.

Relevance 6/10Novelty 5/10Timing: today (analyst downgrade and PT cut)

Background

The piece is an analyst note summary: UBS changes its rating and adjusts the price target for CCEP.

Company-level read

Ticker impact

$CCEPNeutralMedium confidence
Context

UBS downgraded Coca-Cola Europacific Partners to Neutral from Buy and cut its price target to $107 from $109.

Expected impact

Likely modest downside bias or underperformance versus the market until new company-specific catalysts emerge.

Evidence & confidence

The article provides only the analyst action (rating and PT change) without new earnings, guidance, or operational facts.

Market effects

Signals caution on packaged beverages valuation or earnings visibility, potentially affecting sentiment for other European beverage distributors.

Could modestly influence European consumer-staples sentiment around the Euronext listing.

Limited spillover beyond European beverage peers given it is a single-bank rating change.

Counterpoint

The downgrade may be more about valuation than deteriorating fundamentals, so the stock could remain supported if underlying demand trends hold.

Key entities

  • Coca-Cola Europacific Partners

    UBS downgraded the stock to Neutral from Buy and lowered its price target to $107 from $109.

Related articles

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.